Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 2
2000 1
2001 4
2002 8
2003 6
2004 1
2005 2
2006 4
2007 2
2008 7
2009 4
2010 7
2011 2
2012 3
2013 1
2014 4
2015 4
2016 3
2017 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Treatment sequence of synchronously (liver) metastasized colon cancer.
Gruenberger T, Beets G, Van Laethem JL, Rougier P, Cervantes A, Douillard JY, Figueras J, Gruenberger B, Haller DG, Labianca R, Maleux G, Roth A, Ducreux M, Schmiegel W, Seufferlein T, Van Cutsem E. Gruenberger T, et al. Among authors: gruenberger b. Dig Liver Dis. 2016 Oct;48(10):1119-23. doi: 10.1016/j.dld.2016.06.009. Epub 2016 Jun 17. Dig Liver Dis. 2016. PMID: 27375207 Review.
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll E, Thaler J, Keil F, Gruenberger B, Hejna M, Eisterer W, Fridrik MA, Ulmer H, Trommet V, Huemer F, Weiss L, Greil R. Wöll E, et al. Among authors: gruenberger b. Anticancer Res. 2017 Oct;37(10):5553-5558. doi: 10.21873/anticanres.11987. Anticancer Res. 2017. PMID: 28982869 Clinical Trial.
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.
Scheithauer W, Kornek GV, Raderer M, Schüll B, Schmid K, Kovats E, Schneeweiss B, Lang F, Lenauer A, Depisch D. Scheithauer W, et al. Among authors: schull b. J Clin Oncol. 2003 Apr 1;21(7):1307-12. doi: 10.1200/JCO.2003.09.016. J Clin Oncol. 2003. PMID: 12663719 Clinical Trial.
Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response.
Schauer D, Starlinger P, Alidzanovic L, Zajc P, Maier T, Feldman A, Padickakudy R, Buchberger E, Elleder V, Spittler A, Stift J, Pop L, Gruenberger B, Gruenberger T, Brostjan C. Schauer D, et al. Among authors: gruenberger b. Oncoimmunology. 2016 Mar 22;5(6):e1160185. doi: 10.1080/2162402X.2016.1160185. eCollection 2016 Jun. Oncoimmunology. 2016. PMID: 27471631 Free PMC article.
Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regeneration.
Starlinger P, Schauer D, Alidzanovic L, Zikeli S, Gebhardt K, Luf F, Fleischmann E, Perisanidis B, Gruenberger B, Gruenberger T, Brostjan C. Starlinger P, et al. Among authors: gruenberger b. J Hepatol. 2013 May;58(5):1053-4. doi: 10.1016/j.jhep.2012.11.037. Epub 2012 Dec 1. J Hepatol. 2013. PMID: 23207143 Free article. No abstract available.
The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.
Alidzanovic L, Starlinger P, Schauer D, Maier T, Feldman A, Buchberger E, Stift J, Koeck U, Pop L, Gruenberger B, Gruenberger T, Brostjan C. Alidzanovic L, et al. Among authors: gruenberger b. Oncotarget. 2016 Aug 30;7(35):57197-57212. doi: 10.18632/oncotarget.11084. Oncotarget. 2016. PMID: 27527865 Free PMC article.
Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumab.
Farkouh A, Scheithauer W, Buchner P, Georgopoulos A, Schueller J, Gruenberger B, Czejka M. Farkouh A, et al. Among authors: gruenberger b. Anticancer Res. 2014 Jul;34(7):3669-73. Anticancer Res. 2014. PMID: 24982385
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
Glaser CM, Millesi W, Kornek GV, Lang S, Schüll B, Watzinger F, Selzer E, Lavey RS. Glaser CM, et al. Among authors: schull b. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):705-15. doi: 10.1016/s0360-3016(01)01488-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395239
Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S, Stift J, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T. Stremitzer S, et al. Among authors: gruenberger b. Eur J Surg Oncol. 2015 Jul;41(7):868-74. doi: 10.1016/j.ejso.2015.03.223. Epub 2015 Mar 24. Eur J Surg Oncol. 2015. PMID: 25865557 Clinical Trial.
Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction.
Starlinger P, Haegele S, Wanek D, Zikeli S, Schauer D, Alidzanovic L, Fleischmann E, Gruenberger B, Gruenberger T, Brostjan C. Starlinger P, et al. Among authors: gruenberger b. Br J Surg. 2015 Jun;102(7):826-36. doi: 10.1002/bjs.9814. Epub 2015 Apr 13. Br J Surg. 2015. PMID: 25871570 Clinical Trial.
65 results
Jump to page
Feedback